ClinicalTrials.Veeva

Menu

Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Laryngeal Neoplasms

Treatments

Procedure: Transoral robot-assisted tumor resection using the da Vinci robot

Study type

Observational

Funder types

Other

Identifiers

NCT01257633
AOI/2010/BL-01
2010-A01190-39 (Other Identifier)

Details and patient eligibility

About

The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) laryngeal cancer.

Enrollment

54 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The subject has signed consent
  • The subject must be a member or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up
  • The subject has a cancer of the larynx:
  • classified T1 or T2 in the TNM
  • glottic localization and / or supraglottic regardless of node status
  • with or without a history of head and neck cancer
  • The subject does not have distant metastasis (M0)
  • A decision for endoscopic robot-assisted surgery is retained in multidisciplinary meeting

Exclusion criteria

-

Trial design

54 participants in 1 patient group

The study population
Description:
Laryngeal cancer patients requiring surgical tumor resection.
Treatment:
Procedure: Transoral robot-assisted tumor resection using the da Vinci robot

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems